We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+8.78%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.13B
AUM Growth
+$281M
Cap. Flow
+$61.6M
Cap. Flow %
1.97%
Top 10 Hldgs %
12.2%
Holding
1,543
New
228
Increased
546
Reduced
510
Closed
166

Sector Composition

Rank Sector Weight
1 Energy 12.37%
2 Healthcare 10.59%
3 Industrials 9.5%
4 Financials 9.49%
5 Technology 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
76
Amgen
AMGN
$222B
$9M 0.29%
78,903
+4,353
+6% +$495K
IGIB icon
77
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
$8.94M 0.29%
165,768
+36,364
+28% +$1.97M
NVO
78
Novo Nordisk
NVO
$209B
$8.93M 0.29%
483,240
+137,440
+40% +$2.4M
LTM
79
DELISTED
LIFE TIME FITNESS INC
LTM
$8.87M 0.28%
188,670
+24,483
+15% +$1.17M
BND icon
80
Vanguard Total Bond Market
BND
$158B
$8.71M 0.28%
108,767
-13,096
-11% -$1.06M
RDS.A
81
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$8.69M 0.28%
130,488
+4,262
+3% +$268K
IYW icon
82
iShares US Technology ETF
IYW
$25.2B
$8.53M 0.27%
385,852
-15,192
-4% -$316K
DE icon
83
Deere & Co
DE
$168B
$8.52M 0.27%
93,296
+3,138
+3% +$266K
PXD
84
DELISTED
Pioneer Natural Resource Co.
PXD
$8.5M 0.27%
46,160
+722
+2% +$139K
SLB icon
85
SLB Ltd
SLB
$75B
$8.46M 0.27%
93,842
-19,130
-17% -$1.73M
WFC icon
86
Wells Fargo
WFC
$264B
$8.38M 0.27%
184,696
-41,811
-18% -$1.81M
OKE icon
87
Oneok
OKE
$54.5B
$8.37M 0.27%
153,763
+20,306
+15% +$1.02M
VYM icon
88
Vanguard High Dividend Yield ETF
VYM
$82.8B
$8.32M 0.27%
133,531
-2,804
-2% -$169K
DVN icon
89
Devon Energy
DVN
$47.3B
$8.27M 0.26%
133,727
+16,408
+14% +$1.01M
RTX icon
90
RTX Corp
RTX
$301B
$8.18M 0.26%
114,244
+19,849
+21% +$1.35M
UMBF icon
91
UMB Financial
UMBF
$11.1B
$8.06M 0.26%
125,365
+343
+0.3% +$20.8K
VBR icon
92
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.9B
$8.06M 0.26%
82,759
-1,699
-2% -$160K
ORLY icon
93
O'Reilly Automotive
ORLY
$76.3B
$7.98M 0.26%
929,940
+4,650
+0.5% +$39.2K
PSX icon
94
Phillips 66
PSX
$81.4B
$7.94M 0.25%
102,968
-15,678
-13% -$1.05M
IWO icon
95
iShares Russell 2000 Growth ETF
IWO
$15.1B
$7.83M 0.25%
57,749
+6,910
+14% +$895K
MA icon
96
Mastercard
MA
$493B
$7.78M 0.25%
93,170
+2,370
+3% +$176K
WFT
97
DELISTED
Weatherford International plc
WFT
$7.73M 0.25%
498,856
-9,854
-2% -$157K
HYG icon
98
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$7.65M 0.24%
82,392
-4,976
-6% -$462K
APU
99
DELISTED
AmeriGas Partners, L.P.
APU
$7.64M 0.24%
171,339
+16,816
+11% +$732K
NKY
100
DELISTED
PRECIDIAN INVESTMENTS MAXIS NIKKEI 225 INDEX
NKY
$7.63M 0.24%
411,699
-88,602
-18% -$1.57M

Similar funds

Oppenheimer & Co's Q4 2013 Portfolio in Review

As of Q4 2013, Oppenheimer & Co held 1,543 positions worth $3.13B, up 9.9% from $2.84B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co's Q4 2013 filing shows 228 new, 546 increased, 510 reduced and 166 closed positions. Its largest new stake was TetraLogic Pharmaceuticals Corporation: 1,072,115 shares worth $10.2M. The largest sale was WisdomTree Emerging Markets Local Debt Fund, an estimated $5.52M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Industrials.

  • Oppenheimer & Co's largest Q4 2013 buy was TetraLogic Pharmaceuticals Corporation: 1,072,115 shares worth $10.2M.
  • Oppenheimer & Co added most to Invesco FTSE RAFI US 1000 ETF in Q4 2013, an estimated $8.14M increase.
  • Oppenheimer & Co's biggest Q4 2013 reduction was WisdomTree Emerging Markets Local Debt Fund, cutting an estimated $5.52M.
  • Oppenheimer & Co fully exited iShares Global Financials ETF in Q4 2013, selling an estimated $5.36M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.13B portfolio in Q4 2013.
  • Oppenheimer & Co opened 228 new positions and closed 166 in Q4 2013.
  • Oppenheimer & Co's portfolio value rose 9.9% quarter-over-quarter to $3.13B.

Based on Oppenheimer & Co's 13F filing for Q4 2013, filed 12 Feb 2014.